top of page

3D-Side raises funds to continue its growth in the field of arthroplasty in the US.

Updated: Jul 19, 2022

3D-Side closed a €2.7 million Series C investment round. The funds will help strengthening the positioning of the Belgium-based company in the field of arthroplasty. Additionally, the funds will support the launch of 3D-Cut and the guides for corrective osteotomy and bone tumor resection, in the US market.

3D-Side has been world widely recognized for its patient specific surgical technology. Thanks to Artificial Intelligence and strong automation, 3D-Side provides high quality simulations to plan joint replacement, osteotomy, tumor resection and skull procedures. Its Customize software is CE marked and FDA 510(k) cleared.

This 2nd round of funding has been led by the same club of investors through The CLUB DEAL as well as Jean-Marie Berger, an entrepreneur with more than 20 years of experience in the orthopedic industry.

Khanh Tran Duy, CEO said : ‘We are very pleased with the continued success of 3D-Side over the last few years. This new round of funding will allow us to continue to structure the company to meet new challenges and to develop its infrastructure to support its growth in the US in the years to come. We thank all our partners for believing in us and renewing their confidence in our team and our projects’.


bottom of page